Common Contracts

3 similar Securities Purchase Agreement contracts by KALA BIO, Inc.

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 30th, 2024 • KALA BIO, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is made and entered into as of December 29, 2024 (the “Effective Date”) by and among KALA BIO, Inc., a Delaware corporation (the “Company”), and the purchasers listed on the signature pages hereto (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • June 27th, 2024 • KALA BIO, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is made and entered into as of June 26, 2024 (the “Effective Date”) by and among KALA BIO, Inc., a Delaware corporation (the “Company”), and the purchasers listed on the signature pages hereto (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 22nd, 2023 • KALA BIO, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is made and entered into as of December 21, 2023 (the “Effective Date”) by and among KALA BIO, Inc. (formerly Kala Pharmaceuticals, Inc.), a Delaware corporation (the “Company”), and the purchasers listed on the signature pages hereto (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.